Cirugia Cardiovascular is a distinguished open-access journal published by Elsevier, dedicated to advancing the field of cardiovascular surgery and medicine. Established in Spain, this journal serves as a vital platform for disseminating innovative research and clinical insights in the realms of cardiology and surgical practices. With its ISSN 1134-0096 and E-ISSN 1134-0096, Cirugia Cardiovascular has been making impactful contributions to the medical community since becoming an open-access publication in 2005, thus ensuring unrestricted access to critical knowledge. In the most recent evaluation, it was positioned in the Q4 category in both Cardiology and Cardiovascular Medicine and Surgery as of 2023, reflecting its ongoing commitment to improving its scholarly impact. Despite its current ranking within the Scopus database, which highlights its value at percentile ranks of 19th in Surgery and 12th in Cardiology and Cardiovascular Medicine, Cirugia Cardiovascular continues to embrace growth and innovation. The journal aims to unite researchers, clinicians, and students, fostering a collaborative environment to elevate cardiovascular healthcare practices. With a converged year range from 2012 to 2024, it optimally addresses contemporary challenges and advancements in cardiovascular surgical techniques and outcomes.

Annals of Pediatric Cardiology is a distinguished peer-reviewed journal published by Wolters Kluwer Medknow Publications, focusing on the critical intersection of cardiology and pediatric health. Since its inception in 2008 as an Open Access journal, it has been at the forefront of disseminating significant research findings, clinical practices, and advancements in the field of pediatric cardiology. With an ISSN of 0974-2069 and an E-ISSN of 0974-5149, this journal is crucial for researchers, clinicians, and students seeking to enhance their knowledge in cardiological care for children. The journal's impact is underscored by its presence in the Q3 quartile in both Cardiology and Cardiovascular Medicine and Pediatrics, Perinatology, and Child Health categories for 2023, demonstrating its relevance in contemporary medical research. Operating out of India, the journal addresses a gap in pediatric cardiology literature, offering a platform for high-quality research and case studies that inform clinical practice and policy.

Heart Rhythm O2, published by Elsevier and indexed under ISSN 2666-5018, is a premier Open Access journal that has established itself as a vital platform for the dissemination of innovative research in Cardiology and Cardiovascular Medicine. Since its inception in 2020, this journal has rapidly gained recognition, achieving a distinguished Q1 ranking in its field as of 2023, underscoring its commitment to excellence and quality. Operating from its base in the Netherlands, Heart Rhythm O2 aims to bridge the gap between clinical practice and emerging scientific findings, fostering collaboration among researchers, healthcare professionals, and students globally. With a focus on high-impact original research, review articles, and clinical studies, the journal is dedicated to advancing our understanding of cardiac rhythm management and cardiovascular health. With open access options, it ensures that vital knowledge is freely available, facilitating the ongoing education and engagement of the medical community worldwide.

Cardiogenetics, published by MDPI, is a leading open-access journal dedicated to advancing the field of genetics as it pertains to cardiovascular health and diseases. Since its launch in 2011, this journal has been at the forefront of disseminating high-quality research that explores the genetic underpinnings of cardiovascular conditions, offering a platform for innovative studies, reviews, and case reports. With an ISSN of 2035-8253 and an E-ISSN of 2035-8148, Cardiogenetics aims to bridge the gap between genetic research and clinical application, helping researchers, healthcare professionals, and students stay abreast of the latest advancements and findings. The journal’s commitment to open access ensures that its valuable content is available to a global audience, fostering greater collaboration and knowledge sharing in the cardiovascular genetics community. By contributing to this dynamic field, Cardiogenetics plays a crucial role in improving patient outcomes and paving the way for personalized medicine in cardiology.

HEART AND VESSELS is a prominent peer-reviewed journal published by SPRINGER, dedicated to advancing the fields of cardiology and cardiovascular medicine. With its ISSN 0910-8327 and E-ISSN 1615-2573, this esteemed journal encompasses a broad range of topics pertinent to heart health, vascular function, and associated therapies, making it an essential resource for researchers, clinicians, and healthcare professionals alike. Based in Japan and operating since 1985, HEART AND VESSELS has consistently maintained a Q2 ranking in the 2023 category quartiles, highlighting its relevance and impact in the cardio domain. Although it does not offer open access, the journal ensures high-quality publications that contribute significantly to the academic and clinical understanding of cardiovascular health. With over three decades of continuous scholarly contribution, HEART AND VESSELS serves as a vital platform for disseminating cutting-edge research and fostering innovative practices in the management of cardiovascular diseases.

JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, published by Springer, serves as a pivotal platform for advancements in the field of cardiac electrophysiology. With an ISSN of 1383-875X and an E-ISSN of 1572-8595, this esteemed journal has carved out its niche since its inception in 1997, continuing to disseminate critical research up to 2024. Ranked in the Q2 category for Cardiology and Cardiovascular Medicine, as well as in Physiology (medical), the journal is positioned among the top 38% and 53% of its respective fields according to Scopus rankings. This presents a unique opportunity for researchers, healthcare professionals, and students to engage with high-impact studies that drive innovation and knowledge in cardiac health. Although not open access, the journal is accessible through various academic databases, making it a valuable resource for those committed to understanding and enhancing interventional practices in cardiology.

Journal of Cardiology, published by ELSEVIER, stands as a prominent resource in the field of cardiology and cardiovascular medicine. With a rich history since its inception in 1987, this peer-reviewed journal aims to disseminate cutting-edge research that enhances the understanding and treatment of cardiovascular diseases. Its 2023 ranking places it in the Q2 category within its discipline, reflecting its significance and impact, as evidenced by a Scopus rank of #123 out of 387 journals, positioning it in the 68th percentile of its field. The journal is headquartered in Japan, providing a unique perspective on cardiological advances relevant not only to the Asian continent but also globally. Though it does not currently offer open access, the Journal of Cardiology remains a vital institutional resource for researchers, clinicians, and students seeking to push the boundaries of cardiovascular science and improve patient outcomes.

IJC Heart & Vasculature is a premier open-access journal published by Elsevier Ireland Ltd, dedicated to advancing research in the fields of cardiology and cardiovascular medicine. Since its inception in 2013, this journal has established itself as a valuable resource for clinicians, researchers, and students keen on exploring the latest developments in heart and vascular health. With an impressive impact factor and ranked within Q2 in its category (2023), IJC Heart & Vasculature has achieved a significant Scopus rank of #125 out of 387, placing it in the 67th percentile of cardiology journals. The journal not only emphasizes high-quality research but also promotes innovative studies that can shape clinical practices and improve patient outcomes. Researchers and professionals can access a plethora of peer-reviewed articles, original research, and comprehensive reviews that unravel the complexities of cardiovascular science. With a commitment to fostering open and impactful dialogue in the field, IJC Heart & Vasculature is poised to be an essential platform for knowledge exchange in the evolving landscape of cardiovascular research.

JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, published by Wiley, stands at the forefront of the fields of Cardiology and Cardiovascular Medicine, boasting an impressive Impact Factor that reflects its scholarly influence. With a strong focus on innovative research, this esteemed journal has been a vital resource for advancing our understanding of electrophysiological concepts since its inception in 1990. As a Q1 journal in both Cardiology and Physiology (medical) as of 2023, it provides a platform for cutting-edge discoveries and comprehensive reviews that cater to the academic and clinical needs of researchers, practitioners, and students alike. The journal features rigorous peer-reviewed articles that delve into various aspects of cardiovascular health, enhancing both theoretical knowledge and clinical application. Although it does not offer open access, it remains a key resource for those engaged in cardiovascular research, published quarterly through 2024 to ensure timely dissemination of high-quality findings.

KARDIOLOGIYA is a renowned academic journal in the field of cardiology, published by the Russian Heart Failure Society. Since its inception in 1961, this journal has been dedicated to disseminating cutting-edge research in cardiovascular medicine, contributing to the global understanding of heart-related diseases and their management. With a significant publication history that spans over six decades, KARDIOLOGIYA provides a platform for both established researchers and emerging scholars to publish their findings. Despite its current Q4 category ranking in the 2023 Cardiology and Cardiovascular Medicine category, the journal plays a crucial role in promoting regional insights and advancements in cardiology, while striving towards higher visibility and impact within the academic community. While not an open-access journal, the journal is accessible to institutions and professionals in the Russian Federation and beyond, fostering collaboration and knowledge sharing among healthcare professionals. With a Scopus rank of #259 among 387 journals, it is well-positioned to enhance discourse in the field and support the development of innovative approaches to cardiovascular care.